Revenue segments as reported by the company.

Electronics & Industrial

Water & Protection

Corporate & Other

Mobility & Materials

Corporate

Electronics & Imaging

Nutrition & Biosciences

Transportation & Industrial

Safety & Construction

Non-Core

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development expenses

Selling, general and administrative expenses

Amortization of intangibles

Restructuring and asset related charges - net

Goodwill impairment charges

Acquisition, integration and separation costs

Equity in earnings of nonconsolidated affiliates

Sundry income (expense) - net

Interest expense

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

DuPont de Nemours

Danisco is a Danish bio-based company with activities in food production, enzymes and other bioproducts as well as a wide variety of pharmaceutical grade excipients. It was formed in 1989 from the largest Danish industrial merger ever of the two old C.F. Tietgen companies Danish Sugar (founded 1872), and Dansk Handels- og Industri Company (Danisco A/S).

Danisco

Solae was an international soy ingredients supplier based in St. Louis, Missouri. Solae was formed as a joint venture between DuPont and Bunge Limited. On May 1, 2012, Solae announced that DuPont had acquired Bunge's 28% share, thus taking full ownership of the company. DuPont then merged Solae's business into Danisco. The company developed food, feed and industrial ingredients, focusing on soy. Many of the studies supporting the Food and Drug Administration-approved health claim were based on research using Solae soy protein.

Solae

DuPont de Nemours, Inc. is a holding company, which engages in the development of specialty materials, chemicals, and agricultural products. It operates through the following segments: Electronics and Industrial, Water and Protection, and Corporate and Others. The Electronics and Industrial segment involves the supply of differentiated materials and systems for a broad range of consumer electronics including mobile devices, television monitors, personal computers and electronics used in a variety of industries. The Water and Protection segment focuses on the provision of engineered products and integrated systems for many industries including worker safety, water purification and separation, aerospace, energy, medical packaging and building materials. The company was founded in 1897 and is headquartered in Wilmington, DE.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

DuPont reports strong Q4 results, eyes growth amid challenges

DuPont's Q4 performance showcased organic revenue growth and margin improvement, supported by strategic actions and portfolio transformation.
While facing challenges in the shelter business and market conditions, DuPont remains focused on innovation, growth opportunities, and shareholder value enhancement.
The company's outlook for 2023 includes solid top-line growth, operational targets, and a strategic focus on managing challenges and leveraging growth opportunities.

DuPont exceeds Q1 expectations, eyes healthcare growth amid market challenges

DuPont's Q1 performance was solid, with revenue and adjusted EPS surpassing guidance, driven by acquisitions and ongoing market strengths. Challenges in the electronics market and inventory destocking impacted full-year guidance, but opportunities for growth in healthcare and other sectors are on the horizon. The company's focus on sustainability and operational efficiency remains key.

DuPont reports resilient Q2 performance amidst market challenges

DuPont's Q2 performance showed resilience amid market challenges, with a focus on strategic priorities for long-term growth.
While facing volume pressures and market uncertainties, DuPont is leveraging acquisitions and cost controls to drive value.
Opportunities lie in sequential business improvements, cost reductions, and sustainability-focused sales strategies.
Challenges include market-specific declines and regional growth variations that require strategic adjustments.

DuPont reports solid Q3 earnings amidst China challenges and growth opportunities

DuPont's Q3 performance showcased resilience amid challenges, with revenue declines offset by improved margins and EPS growth. Strategic acquisitions and divestitures are driving the company forward.
Despite facing headwinds in China and inventory destocking, DuPont is capitalizing on opportunities in semiconductors and other key segments. Efforts to enhance efficiency and target growth areas position the company for future success.
While challenges like trade restrictions and industrial destocking persist, DuPont remains focused on leveraging growth opportunities in AI, electronics, and other segments. Maintaining a strong cash position and returning value to shareholders are key priorities.

DuPont reports Q4 2023 results, eyes growth in key markets

DuPont's Q4 performance saw declines in net sales and EBITDA, but the company remains resilient amidst market challenges. Cost-saving initiatives and share repurchase programs demonstrate strategic financial management.
Despite absorption headwinds and challenges in China, DuPont's focus on key markets like semiconductors and water positions it for growth. The company's long-term EBITDA margin outlook is positive.
Opportunities in market stabilization, recovery in key sectors, and potential growth in water and electronics segments offer DuPont avenues for future expansion and profitability.

DuPont surpasses Q1 expectations, eyes growth amid market challenges

DuPont's Q1 2024 performance exceeded expectations, prompting an upward revision of full-year guidance across key financial metrics.
The company's focus on operational excellence, sustainability, and market diversification positions it well for recovery and growth in 2024 and beyond.
While facing challenges in pricing and market dynamics, DuPont's strategic initiatives and opportunities in key segments offer avenues for future growth.
Overall, DuPont's strong performance, prudent risk management, and focus on innovation and efficiency underscore its resilience and potential for sustained success.

DuPont surpasses Q2 expectations, eyes growth in tech and China

DuPont delivered strong Q2 2024 results, exceeding guidance and showcasing resilience across key segments.
Strategic initiatives like the Donatelle acquisition and planned separation activities position DuPont for future growth and market leadership.
While legal challenges persist, DuPont's proactive approach and focus on innovation and diversification bode well for long-term success.

DuPont reports strong Q3 earnings and progresses on strategic separations

DuPont's Q3 earnings call reflects a robust performance with growth in key financial metrics and segments. The company's focus on operational excellence and strategic initiatives has positioned it for continued success. While challenges exist, DuPont's ability to capitalize on opportunities and drive innovation bodes well for future growth and value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

WILMINGTON, Del. , May 17, 2023 /PRNewswire/ -- DuPont (NYSE: DD) today announced it has been Certified™ by Great Place to Work®, the global authority on workplace culture, employee experience, and leadership behaviors required for market-leading revenue, employee retention and innovation.

DuPont Earns Great Place to Work Certification™

MENLO PARK, Calif.--(BUSINESS WIRE)--Sofinnova Investments Appoints Dr. Jakob Dupont as Executive Partner.

Sofinnova Investments Appoints Dr. Jakob Dupont as Executive Partner

Albemarle

Albemarle Corporation (NYSE:ALB) and DuPont de Nemours Inc (NYSE:DD) both sport healthy leads this morning, after analysts upgraded the two stocks.

2 Stocks Popping After Analyst Upgrades

Recognized as a Key Contributor to the Water Project of the Year – the Jiaxing Drinking Water Upgrade Project in China WILMINGTON, Del. , May 15, 2023 /PRNewswire/ -- DuPont Water Solutions has been named Water Technology Company of the Year, presented at the Global Water Awards, for innovating solutions to sustainably address the hardest global water challenges.

DuPont Water Solutions Named 2023 Water Technology Company of the Year

Shares of DuPont de Nemours Inc. took a deep dive Tuesday, after the technology-based materials and plastics company lowered its full-year outlook, as weakness in the consumer electronics markets is seen continuing for longer than previously projected.

DuPont sees weak smartphone, PC and chip demand, as consumers slow spending on electronics

DuPont (NYSE:DD), the American chemical giant shares fell sharply following its 1Q earnings release despite beating estimates on earnings and revenue. The firm posted a decrease in net sales of 8% to $3 billion for the first quarter of 2023 as a lower volume environment hit its electronics and construction-related end markets, according to the company.

DuPont shares plunge as full-year 2023 outlook disappoints; inks $1.8B deal for Spectrum Plastics

DuPont de Nemours, Inc. (NYSE:DD ) Q1 2023 Earnings Conference Call May 2, 2023 8:00 AM ET Company Participants Chris Mecray - Vice President, Investor Relations Ed Breen - Chief Executive Officer Lori Koch - Chief Financial Officer Conference Call Participants Steve Tusa - JPMorgan Jeff Sprague - Vertical Research Scott Davis - Melius Research Christopher Parkinson - Mizuho Mike Leithead - Barclays Aleksey Yefremov - KeyBanc Vincent Andrews - Morgan Stanley Josh Spector - UBS John Roberts - Credit Suisse Steve Byrne - Bank of America John McNulty - BMO Capital Markets David Begleiter - Deutsche Bank Arun Viswanathan - RBC Capital Markets Mike Sison - Wells Fargo Operator Ladies and gentlemen, thank you for standing by, and welcome to the DuPont First Quarter 2023 Earnings Call. I would now like to turn the call over to Chris Mecray, Head of Investor Relations.

DuPont de Nemours, Inc. (DD) Q1 2023 Earnings Call Transcript

DuPont (DD) gains on higher pricing in Q1 amid headwinds from weak conditions in electronics and construction end markets.

DuPont's (DD) Earnings and Revenues Top Estimates in Q1

DuPont de Nemours (DD) came out with quarterly earnings of $0.84 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.82 per share a year ago.

DuPont de Nemours (DD) Beats Q1 Earnings and Revenue Estimates

DuPont's first-quarter earnings top estimates but the materials giant reduces full-year guidance.

DuPont Beats Earnings Estimates. Why the Stock Is Falling.

DuPont de Nemours Inc. DD reported Tuesday first-quarter profit and sales that beat expectations, as growth in its water and protection business offset weakness in electronics and industrial business, but trimmed its full-year outlook. Shares of the specialty materials and chemical company were still inactive in the premarket.

DuPont beats profit and sales expectations, but trims full-year guidance ranges

DuPont de Nemours Inc. DD said Tuesday it has reached an agreement to acquire Spectrum Plastics Group from AEA Investors for $1.75 billion cash. Spectrum is a manufacturer of specialty medical devices and components and serves 22 of the 26 top medical device original equipment manufacturers with a focus on fast-growing therapeutics areas such as structural heart, electrophysiology, surgical robotics and cardiovascular, Dupont said in a statement.

DuPont to acquire Spectrum Plastics from AEA Investors for $1.75 billion in cash

Net Sales of $3.0 billion decreased 8%; organic sales decreased 3% versus year-ago period GAAP Income from continuing operations of $273 million; operating EBITDA of $714 million GAAP EPS from continuing operations of $0.58; adjusted EPS of $0.84 Operating cash flow of $343 million; adjusted free cash flow of $102 million WILMINGTON, Del. , May 2, 2023 /PRNewswire/ -- DuPont (NYSE: DD) today announced financial results(1) for the first quarter ended March 31, 2023.

DuPont Reports First Quarter 2023 Results

Complements existing offerings for biopharma and pharma processing, medical devices and packaging, including DuPont's Liveo™ silicone solutions and Tyvek ® Medical Packaging. Strengthens DuPont's position in fast-growing, low cyclicality healthcare markets.

DuPont to Acquire Spectrum Plastics Group from AEA Investors

WILMINGTON, Del. , May 1, 2023 /PRNewswire/ -- DuPont (NYSE: DD) today published its 2023 Sustainability Report detailing the progress made toward achieving its 2030 Sustainability Goals.

DuPont Publishes 2023 Sustainability Report

Axalta Coating Systems

LyondellBasell Industries

While softer demand in certain end markets is likely to be a drag, Albemarle (ALB), DuPont (DD), Axalta (AXTA) and LyondellBasell (LYB) are likely to have benefited from cost and pricing actions in Q1.

4 Chemical Stocks Poised to Outshine Q1 Earnings Estimates

DuPont de Nemours (DD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DuPont de Nemours (DD) Expected to Beat Earnings Estimates: Should You Buy?

HOUSTON — A chemical company was ordered to pay $16 million and sentenced to two years of probation for its role in a poisonous gas leak that killed four workers at a Houston-area plant nearly a decade ago, federal prosecutors announced Monday.

DuPont ordered to pay $16 million in Texas plant leak that killed 4

Announces new 2030 climate targets - increases its Scope 1 and 2 GHG emissions reduction goal to 50% and establishes a Scope 3 GHG emissions reduction goal WILMINGTON, Del. , April 24, 2023 /PRNewswire/ -- DuPont (NYSE: DD) today announced that its 2030 emissions reduction targets have been validated by the Science Based Target Initiative (SBTi), a partnership between CDP, the UN Global Compact, World Resources Institute (WRI) and the World Wide Fund for Nature (WWF).

DuPont Strengthens Science-based Climate Goals and Receives Target Validation from SBTi

Two Silver Awards and One Bronze highlight sustainable technologies WILMINGTON, Del. , April 21, 2023 /PRNewswire/ -- DuPont (NYSE:DD) today announced that three of its innovative material technologies were recognized with the prestigious 2023 Edison Awards™.

DuPont Wins Three 2023 Edison Awards™

RONKONKOMA, N.Y.--(BUSINESS WIRE)--Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to announce it has teamed up with DuPont™ Liveo™ Healthcare Solutions, a leader in the innovative design and production of solutions for biopharmaceutical, pharmaceutical and medical device markets. As part of this collaboration, Qosina has added five new Liveo™ biopharmaceutical-grade tubing products to its extensive tubing portfolio.

Qosina Teams up with DuPont™ Liveo™ Healthcare Solutions to Market Its Liveo™ Biopharmaceutical-grade Tubing

WILMINGTON, Del. , April 20, 2023 /PRNewswire/ -- DuPont (NYSE: DD) today announced Appaloosa Run Wind Energy Center, a wind energy project resulting from a virtual power purchase agreement (VPPA) with a subsidiary of NextEra Energy Resources, LLC, is operational and generating clean, renewable energy.

DuPont to Source Renewable Energy Through Wind Energy Center in Texas

ArcelorMittal

Nutrien

BioNTech SE

General Motors

Labcorp Holdings Inc

While the concept of acquiring low-PE ratio blue-chip stocks (that is, industry-leading stalwarts that feature low price-earnings ratios relative to their sectors) appeals on paper, investors need to be cautious. You can't just buy companies based on any one single metric.

7 Low-PE Ratio Blue-Chip Stocks Offering Both Quality and Value

DuPont (DD) Kevlar EXO offers never-before-seen ballistic and thermal performance while simultaneously providing a flexible and lightweight solution that enables users to operate at peak performance.

DuPont (DD) Unveils Kevlar EXO Next-Generation Aramid Fiber

WILMINGTON, Del. , April 18, 2023 /PRNewswire/ -- DuPont (NYSE: DD) will release its first quarter 2023 financial results at 6:00 a.m.

News for DuPont de Nemours Stock (DD)